These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15809494)

  • 1. Radiopharmaceutical chemistry of targeted radiotherapeutics, part 1: effects of solvent on the degradation of radiohalogenation precursors by 211At alpha-particles.
    Pozzi OR; Zalutsky MR
    J Nucl Med; 2005 Apr; 46(4):700-6. PubMed ID: 15809494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiopharmaceutical chemistry of targeted radiotherapeutics, Part 2: radiolytic effects of 211At alpha-particles influence N-succinimidyl 3-211AT-astatobenzoate synthesis.
    Pozzi OR; Zalutsky MR
    J Nucl Med; 2005 Aug; 46(8):1393-400. PubMed ID: 16085599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiopharmaceutical chemistry of targeted radiotherapeutics, Part 3: alpha-particle-induced radiolytic effects on the chemical behavior of (211)At.
    Pozzi OR; Zalutsky MR
    J Nucl Med; 2007 Jul; 48(7):1190-6. PubMed ID: 17574991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
    Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
    J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiopharmaceutical chemistry of targeted radiotherapeutics, part 4: Strategies for
    Pozzi OR; Zalutsky MR
    Nucl Med Biol; 2017 Mar; 46():43-49. PubMed ID: 28013121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugate.
    Zalutsky MR; McLendon RE; Garg PK; Archer GE; Schuster JM; Bigner DD
    Cancer Res; 1994 Sep; 54(17):4719-25. PubMed ID: 8062270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-level production of alpha-particle-emitting (211)At and preparation of (211)At-labeled antibodies for clinical use.
    Zalutsky MR; Zhao XG; Alston KL; Bigner D
    J Nucl Med; 2001 Oct; 42(10):1508-15. PubMed ID: 11585865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab')2.
    Elgqvist J; Andersson H; Bernhardt P; Bäck T; Claesson I; Hultborn R; Jensen H; Johansson BR; Lindegren S; Olsson M; Palm S; Warnhammar E; Jacobsson L
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1228-37. PubMed ID: 17145538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labeling Monoclonal Antibody with α-emitting
    Vaidyanathan G; Pozzi OR; Choi J; Zhao XG; Murphy S; Zalutsky MR
    Cancer Biother Radiopharm; 2020 Sep; 35(7):511-519. PubMed ID: 32109139
    [No Abstract]   [Full Text] [Related]  

  • 10. Reagents for astatination of biomolecules: comparison of the in vivo distribution and stability of some radioiodinated/astatinated benzamidyl and nido-carboranyl compounds.
    Wilbur DS; Chyan MK; Hamlin DK; Kegley BB; Risler R; Pathare PM; Quinn J; Vessella RL; Foulon C; Zalutsky M; Wedge TJ; Hawthorne MF
    Bioconjug Chem; 2004; 15(1):203-23. PubMed ID: 14733601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation.
    Larsen RH; Murud KM; Akabani G; Hoff P; Bruland OS; Zalutsky MR
    J Nucl Med; 1999 Jul; 40(7):1197-203. PubMed ID: 10405142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution of 211At labeled HER-2 binding affibody molecules in mice.
    Steffen AC; Almqvist Y; Chyan MK; Lundqvist H; Tolmachev V; Wilbur DS; Carlsson J
    Oncol Rep; 2007 May; 17(5):1141-7. PubMed ID: 17390057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy.
    Zalutsky MR; Vaidyanathan G
    Curr Pharm Des; 2000 Sep; 6(14):1433-55. PubMed ID: 10903402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
    Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
    Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular-targeted radioimmunotherapy with the alpha-particle emitter 211At.
    Kennel SJ; Mirzadeh S; Eckelman WC; Waldmann TA; Garmestani K; Yordanov AT; Stabin MG; Brechbiel MW
    Radiat Res; 2002 Jun; 157(6):633-41. PubMed ID: 12005541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal alpha-particle radioimmunotherapy of ovarian cancer patients: pharmacokinetics and dosimetry of (211)At-MX35 F(ab')2--a phase I study.
    Andersson H; Cederkrantz E; Bäck T; Divgi C; Elgqvist J; Himmelman J; Horvath G; Jacobsson L; Jensen H; Lindegren S; Palm S; Hultborn R
    J Nucl Med; 2009 Jul; 50(7):1153-60. PubMed ID: 19525452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct procedure for the production of 211At-labeled antibodies with an epsilon-lysyl-3-(trimethylstannyl)benzamide immunoconjugate.
    Lindegren S; Frost S; Bäck T; Haglund E; Elgqvist J; Jensen H
    J Nucl Med; 2008 Sep; 49(9):1537-45. PubMed ID: 18703591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunotherapy with alpha-particle emitting radionuclides.
    Zalutsky MR; Pozzi OR
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effects of free 211At,211At-albumin and 211At-monoclonal antibody compared to external photon irradiation on two human cancer cell lines.
    Palm S; Andersson H; Bäck T; Claesson I; Delle U; Hultborn R; Jacobsson L; Köpf I; Lindegren S
    Anticancer Res; 2000; 20(2A):1005-12. PubMed ID: 10810388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the 210At impurity in the production of 211At for radiotherapy by 210Po analysis via isotope dilution alpha spectrometry.
    Schultz MK; Hammond M; Cessna JT; Plascjak P; Norman B; Szajek L; Garmestani K; Zimmerman BE; Unterweger M
    Appl Radiat Isot; 2006; 64(10-11):1365-9. PubMed ID: 16563782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.